Literature DB >> 11171941

International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.

B S Khakh1, G Burnstock, C Kennedy, B F King, R A North, P Séguéla, M Voigt, P P Humphrey.   

Abstract

ATP acts as a humoral mediator to control cell function extracellularly. The receptors that mediate the actions of ATP belong to two classes, the metabotropic P2Y receptors and the transmitter-gated, ion channel P2X receptors. This review describes the structure, distribution, function, and ligand recognition characteristics of P2X receptors, which comprise seven distinct subunits that can function as both homo- and hetero- polymers. The pharmacology of P2X receptors is complicated by marked differences between species orthologues. The current nomenclature is based largely on recombinant receptor studies and detailed knowledge of endogenous P2X receptors in native tissues is limited because of lack of good selective agonists and antagonists for each receptor type.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11171941

Source DB:  PubMed          Journal:  Pharmacol Rev        ISSN: 0031-6997            Impact factor:   25.468


  203 in total

1.  Activation-dependent changes in receptor distribution and dendritic morphology in hippocampal neurons expressing P2X2-green fluorescent protein receptors.

Authors:  B S Khakh; W B Smith; C S Chiu; D Ju; N Davidson; H A Lester
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

Review 2.  The developing relationship between receptor-operated and store-operated calcium channels in smooth muscle.

Authors:  Ian McFadzean; Alan Gibson
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

3.  On the contribution of the first transmembrane domain to whole-cell current through an ATP-gated ionotropic P2X receptor.

Authors:  W R Haines; M M Voigt; K Migita; G E Torres; T M Egan
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

4.  A truncated P2X7 receptor variant (P2X7-j) endogenously expressed in cervical cancer cells antagonizes the full-length P2X7 receptor through hetero-oligomerization.

Authors:  Ying-Hong Feng; Xin Li; Liqin Wang; Lingying Zhou; George I Gorodeski
Journal:  J Biol Chem       Date:  2006-04-18       Impact factor: 5.157

Review 5.  Purinergic regulation of epithelial transport.

Authors:  R Elaine Bucheimer; Joel Linden
Journal:  J Physiol       Date:  2003-12-23       Impact factor: 5.182

6.  Adenine nucleotides inhibit recombinant N-type calcium channels via G protein-coupled mechanisms in HEK 293 cells; involvement of the P2Y13 receptor-type.

Authors:  Kerstin Wirkner; Joana Schweigel; Zoltan Gerevich; Heike Franke; Clemens Allgaier; Edward Leon Barsoumian; Henning Draheim; Peter Illes
Journal:  Br J Pharmacol       Date:  2003-12-08       Impact factor: 8.739

7.  Functionalized congeners of tyrosine-based P2X(7) receptor antagonists: probing multiple sites for linking and dimerization.

Authors:  Wangzhong Chen; R Gnana Ravi; Sylvia B Kertesy; George R Dubyak; Kenneth A Jacobson
Journal:  Bioconjug Chem       Date:  2002 Sep-Oct       Impact factor: 4.774

Review 8.  Electrophysiological properties of NG2(+) cells: Matching physiological studies with gene expression profiles.

Authors:  Valerie A Larson; Ye Zhang; Dwight E Bergles
Journal:  Brain Res       Date:  2015-09-15       Impact factor: 3.252

9.  Expression and function of P2X purinoceptors in rat histaminergic neurons.

Authors:  Vladimir S Vorobjev; Irina N Sharonova; Helmut L Haas; Olga A Sergeeva
Journal:  Br J Pharmacol       Date:  2003-03       Impact factor: 8.739

Review 10.  Crossing the pain barrier: P2 receptors as targets for novel analgesics.

Authors:  C Kennedy; T S Assis; A J Currie; E G Rowan
Journal:  J Physiol       Date:  2003-09-26       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.